Tirzepatide is a next-generation treatment for type 2 diabetes and weight management. Unlike traditional therapies, it is the first dual-action medication that targets both GIP and GLP-1 receptors to help regulate blood sugar and support metabolic health.

By working with the body’s natural hormones, tirzepatide helps:

• Increase insulin release when blood sugar is high

• Reduce excess glucose production by the liver

• Slow digestion to promote longer-lasting fullness

• Decrease appetite and support weight loss

Clinical studies have shown significant improvements in HbA1c, fasting glucose levels, and body weight. Most patients tolerate treatment well, with side effects generally mild and manageable.

For best results, tirzepatide dosing is gradually increased to help minimise nausea and digestive discomfort.